Balance Sheet
Cash Flow Statement
AmortizationBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abivax (ABVX) Net Income (2022 - 2025)

Historic Net Income for Abivax (ABVX) over the last 2 years, with Q3 2025 value amounting to -$179.3 million.

  • Abivax's Net Income fell 19559.75% to -$179.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$331.3 million, marking a year-over-year decrease of 12236.01%. This contributed to the annual value of -$188.3 million for FY2024, which is 1784.49% down from last year.
  • Per Abivax's latest filing, its Net Income stood at -$179.3 million for Q3 2025, which was down 19559.75% from -$54.8 million recorded in Q2 2025.
  • In the past 5 years, Abivax's Net Income registered a high of -$41.8 million during Q2 2024, and its lowest value of -$179.3 million during Q3 2025.